Home › Companies › CARA THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and CARA THERAPEUTICS INC.’s Form 8-K, filed 2024-06-07 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2023-2024
Explore CARA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are CARA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-07 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Susan Shiff, Ph.D. | 20,753,354 | -- | -- | 6,256,188 | 12,814,548 | Majority: yes |
| Elect Director: Helen M. Boudreau | 26,317,774 | -- | -- | 691,768 | 12,814,548 | Majority: yes |
| Proposal 4: Increase the Authorized Shares of Common Stock The stockholders approved the amendment of the Company's Certificate of Incorporation to increase the authorized number of shares of common stock from 100,000,000 to 200,000,000, by the following votes | 36,799,337 | 2,931,128 | 93,625 | -- | 0 | Majority: yes |
| Proposal 5: Series of Alternate Amendments to Effect a Reverse Stock Split and Effect a Proportionate Reduction in the Total Number of Authorized Shares of Common Stock The stockholders approved series of alternate amendments to the Company's Amended and Resta | 37,402,816 | 2,269,731 | 151,543 | -- | 0 | Majority: yes |
Source: CARA THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-07 — read the filing on EDGAR.
Each item below shows how the 120 asset managers that disclosed a CARA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CARA THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
32% fund support · no official result
The 120 asset managers below cast 32% of the shares they voted on this item FOR (5,227,428 for, 11,100,651 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 15,082 | 2,575,176 | 0 | 0 | Against |
| Vanguard | 2,487,115 | 0 | 0 | 0 | For |
| Chescapmanager LLC | 1,702,089 | 0 | 0 | 0 | For |
| DISCIPLINED GROWTH INVESTORS INC /MN | 0 | 1,600,555 | 0 | 0 | Against |
| FARALLON CAPITAL MANAGEMENT LLC | 0 | 1,112,688 | 0 | 0 | Against |
| Fidelity | 0 | 988,391 | 0 | 0 | Against |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 844,852 | 0 | 0 | Against |
| Two Sigma | 0 | 750,947 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 717,399 | 0 | 0 | Against |
| State Street | 670,077 | 3,362 | 0 | 0 | For |
| Charles Schwab | 0 | 657,902 | 0 | 0 | Against |
| Voya | 0 | 403,742 | 0 | 0 | Against |
| Renaissance | 0 | 340,753 | 0 | 0 | Against |
| Northern Trust | 224,713 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 184,640 | 0 | 0 | Against |
| Equitable | 0 | 174,048 | 0 | 0 | Against |
| AllianceBernstein | 0 | 87,320 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 77,774 | 0 | 0 | Against |
| DE Shaw | 0 | 77,464 | 0 | 0 | Against |
| Ensign Peak Advisors, Inc | 54,897 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,200 | 0 | 0 | 0 | For |
| Rhumbline | 0 | 25,429 | 0 | 0 | Against |
| Fidelis Capital Partners, LLC | 0 | 25,403 | 0 | 0 | Against |
| Goldman Sachs | 131 | 25,031 | 0 | 0 | Against |
| John Hancock | 0 | 23,722 | 0 | 0 | Against |
Showing the 25 largest of 120 asset managers. See all 120 in the interactive database.
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
CARA THERAPEUTICS INC.’s own tally for this item (“Proposal 5: Series of Alternate Amendments to Effect a Reverse Stock Split and Effect a Proportionate Reduction in the Total Number of Authorized Shares of Common Stock The stockholders approved series of alternate amend”): 37,402,816 for, 2,269,731 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,675,954 outstanding shares: 68% for, 4% against (73% of the company cast a for/against vote).
The 30 asset managers below cast 100% of the shares they voted on this item FOR (5,312,784 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,448,409 | 0 | 0 | 0 | For |
| BlackRock | 1,045,222 | 0 | 0 | 0 | For |
| Fidelity | 819,543 | 0 | 0 | 0 | For |
| Charles Schwab | 328,951 | 0 | 0 | 0 | For |
| Voya | 201,871 | 0 | 0 | 0 | For |
| Equitable | 174,048 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 77,774 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,200 | 0 | 0 | 0 | For |
| Northern Trust | 22,810 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,084 | 0 | 0 | 0 | For |
| Pacific Life | 17,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,222 | 0 | 0 | 0 | For |
| John Hancock | 11,861 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 10,900 | 0 | 0 | 0 | For |
| Nationwide | 10,791 | 0 | 0 | 0 | For |
| Legg Mason | 10,463 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 9,986 | 0 | 0 | 0 | For |
| SEI | 9,400 | 0 | 0 | 0 | For |
| ProShares | 9,265 | 0 | 0 | 0 | For |
| DWS | 8,323 | 0 | 0 | 0 | For |
| Principal | 6,521 | 0 | 0 | 0 | For |
| State Street | 3,343 | 0 | 0 | 0 | For |
| Calvert | 3,311 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,330 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,882 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
CARA THERAPEUTICS INC.’s own tally for this item (“Proposal 4: Increase the Authorized Shares of Common Stock The stockholders approved the amendment of the Company's Certificate of Incorporation to increase the authorized number of shares of common stock from 100,000,00”): 36,799,337 for, 2,931,128 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,675,954 outstanding shares: 67% for, 5% against (73% of the company cast a for/against vote).
The 30 asset managers below cast 97% of the shares they voted on this item FOR (5,153,690 for, 159,094 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,448,409 | 0 | 0 | 0 | For |
| BlackRock | 1,045,222 | 0 | 0 | 0 | For |
| Fidelity | 660,449 | 159,094 | 0 | 0 | For |
| Charles Schwab | 328,951 | 0 | 0 | 0 | For |
| Voya | 201,871 | 0 | 0 | 0 | For |
| Equitable | 174,048 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 77,774 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,200 | 0 | 0 | 0 | For |
| Northern Trust | 22,810 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,084 | 0 | 0 | 0 | For |
| Pacific Life | 17,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,222 | 0 | 0 | 0 | For |
| John Hancock | 11,861 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 10,900 | 0 | 0 | 0 | For |
| Nationwide | 10,791 | 0 | 0 | 0 | For |
| Legg Mason | 10,463 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 9,986 | 0 | 0 | 0 | For |
| SEI | 9,400 | 0 | 0 | 0 | For |
| ProShares | 9,265 | 0 | 0 | 0 | For |
| DWS | 8,323 | 0 | 0 | 0 | For |
| Principal | 6,521 | 0 | 0 | 0 | For |
| State Street | 3,343 | 0 | 0 | 0 | For |
| Calvert | 3,311 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,330 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,882 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CARA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Helen M. Boudreau”): 26,317,774 for, 691,768 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,675,954 outstanding shares: 48.1% for, 1% withheld (49.4% of the company cast a for/withheld vote).
The 30 asset managers below cast 100% of the shares they voted on this item FOR (5,312,784 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,448,409 | 0 | 0 | 0 | For |
| BlackRock | 1,045,222 | 0 | 0 | 0 | For |
| Fidelity | 819,543 | 0 | 0 | 0 | For |
| Charles Schwab | 328,951 | 0 | 0 | 0 | For |
| Voya | 201,871 | 0 | 0 | 0 | For |
| Equitable | 174,048 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 77,774 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,200 | 0 | 0 | 0 | For |
| Northern Trust | 22,810 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,084 | 0 | 0 | 0 | For |
| Pacific Life | 17,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,222 | 0 | 0 | 0 | For |
| John Hancock | 11,861 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 10,900 | 0 | 0 | 0 | For |
| Nationwide | 10,791 | 0 | 0 | 0 | For |
| Legg Mason | 10,463 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 9,986 | 0 | 0 | 0 | For |
| SEI | 9,400 | 0 | 0 | 0 | For |
| ProShares | 9,265 | 0 | 0 | 0 | For |
| DWS | 8,323 | 0 | 0 | 0 | For |
| Principal | 6,521 | 0 | 0 | 0 | For |
| State Street | 3,343 | 0 | 0 | 0 | For |
| Calvert | 3,311 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,330 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,882 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 4 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
CARA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Susan Shiff, Ph.D.”): 20,753,354 for, 6,256,188 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,675,954 outstanding shares: 38% for, 11% withheld (49.4% of the company cast a for/withheld vote).
The 30 asset managers below cast 99.9% of the shares they voted on this item FOR (3,517,523 for, 364 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,448,409 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 1,045,222 | 0 | Abstain |
| Fidelity | 660,449 | 0 | 159,094 | 0 | For |
| Charles Schwab | 328,951 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 201,871 | 0 | Abstain |
| Equitable | 0 | 0 | 174,048 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 77,774 | 0 | Abstain |
| Lincoln Financial | 39,200 | 0 | 0 | 0 | For |
| Northern Trust | 22,810 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 21,084 | 0 | Abstain |
| Pacific Life | 0 | 0 | 17,348 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 14,222 | 0 | Abstain |
| John Hancock | 0 | 0 | 11,861 | 0 | Abstain |
| Blackstone Alternative Investment Funds | 0 | 0 | 10,900 | 0 | Abstain |
| Nationwide | 0 | 0 | 10,791 | 0 | Abstain |
| Legg Mason | 0 | 0 | 10,463 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 9,986 | 0 | Abstain |
| SEI | 9,400 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 9,265 | 0 | Abstain |
| DWS | 0 | 0 | 8,323 | 0 | Abstain |
| Principal | 0 | 0 | 6,521 | 0 | Abstain |
| State Street | 3,343 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 3,311 | 0 | Abstain |
| T. Rowe Price | 2,330 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 0 | 1,882 | 0 | Abstain |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% fund support · no official result
The 30 asset managers below cast 100% of the shares they voted on this item FOR (5,312,784 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,448,409 | 0 | 0 | 0 | For |
| BlackRock | 1,045,222 | 0 | 0 | 0 | For |
| Fidelity | 819,543 | 0 | 0 | 0 | For |
| Charles Schwab | 328,951 | 0 | 0 | 0 | For |
| Voya | 201,871 | 0 | 0 | 0 | For |
| Equitable | 174,048 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 77,774 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,200 | 0 | 0 | 0 | For |
| Northern Trust | 22,810 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,084 | 0 | 0 | 0 | For |
| Pacific Life | 17,348 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,222 | 0 | 0 | 0 | For |
| John Hancock | 11,861 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 10,900 | 0 | 0 | 0 | For |
| Nationwide | 10,791 | 0 | 0 | 0 | For |
| Legg Mason | 10,463 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 9,986 | 0 | 0 | 0 | For |
| SEI | 9,400 | 0 | 0 | 0 | For |
| ProShares | 9,265 | 0 | 0 | 0 | For |
| DWS | 8,323 | 0 | 0 | 0 | For |
| Principal | 6,521 | 0 | 0 | 0 | For |
| State Street | 3,343 | 0 | 0 | 0 | For |
| Calvert | 3,311 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,330 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,882 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Ranked by the number of CARA THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 54,675,954 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 4.74% |
| 2 | Vanguard | 4.55% |
| 3 | Chescapmanager LLC | 3.11% |
| 4 | DISCIPLINED GROWTH INVESTORS INC /MN | 2.93% |
| 5 | FARALLON CAPITAL MANAGEMENT LLC | 2.04% |
| 6 | Fidelity | 1.81% |
| 7 | STIFEL NICOLAUS & CO INC \MO\ | 1.55% |
| 8 | Two Sigma | 1.37% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.31% |
| 10 | State Street | 1.23% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vifor (International) Ltd | 13.53% | DEF14A |
| Blackrock, Inc. | 6.50% | DEF14A |
| The Vanguard Group | 4.81% | 13G |
| Renaissance Technologies | 2.44% | 13F |
| Geode Capital | 1.87% | 13F |
| State Street | 1.83% | 13F |
| Christopher Posner | 1.23% | DEF14A |
| Millennium Management | 1.21% | 13F |
| Joana Goncalves, M.D. | 0.77% | DEF14A |
| Northern Trust | 0.71% | 13F |
Percentages above are of 54,675,954 shares outstanding, as reported by CARA THERAPEUTICS INC. on its Form 10-Q dated 2024-05-09 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CARA THERAPEUTICS INC.’s 10-Q dated 2024-05-09. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At CARA THERAPEUTICS INC.'s shareholder meeting held 2024-06-04, in the 2023-2024 proxy season, 120 asset managers reported how they voted in their SEC Form N-PX filings, covering 632 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. CARA THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval of, on a non-binding, advisory basis, the compensation of the Company's named… — the reporting funds cast 32% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
CARA THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page).